BIT's 1st World Congress of Virus and Infections - 2010

Dalian, China (PressExposure) February 01, 2010 -- The 1st World Congress of Virus and Infections is the extension of the previous two annual World Summits of Antivirals. There are 3 parallel symposia at this congress: 1st World Congress of Virus and Infections, 1st Annual Inaugurate Symposium of Hepatitis Virus and 3rd Annual World Summit of Antivirals. WCVI 2010 will set World Summit of Antivirals as the essence, arrange a unique symposium for hepatitis virus and enlarge its involvement in animal and plant antivirals. There is also a large poster session arranged for young scientists to have them heard by the worldwide professionals.

3 Parallel sub-conferences of more than 150 remarkable sessions 1000 scientific and technological posters to share the new findings and breakthroughs 500-800 parallel presentations and discussions on update current novel R & D status 100-150 exhibitors to demonstrate their products and technology development 100 Showcases for most promising and fast growing companies in antiviral R & D Special tailored 1 to 1 network for business and collaboration demands

For Press and Media Ms. April Wang BIT Life Sciences, Inc 26 Gaoneng St., R405, Dalian Hightech Zone Dalian, LN 116025, China Tel: 0086-411-84795469 Fax: 0086-411-84799629 Email: april@bitlifesciences.com Website: http://www.bitlifesciences.com/wcvi2010 BIT Life Sciences, Inc http://www.biteomics.com

Theme Voice of Virologists

Time July 31-August 3, 2010 Place BEXCO, Busan, South Korea Website http://www.bitlifesciences.com/wcvi2010

For Press and Media Ms. April Wang BIT Life Sciences, Inc 26 Gaoneng St., R405, Dalian Hightech Zone Dalian, LN 116025, China

About BIT

Dalian Biteomics, Inc. is a high-tech biological company established by overseas Chinese scientists, specializing in integration of current Chinese and overseas social and technological resources, providing frontier technologies and product services for human health and biological careers. Now the business of our company covers drug discovery, peptide synthesis, distribution of biological enzyme, and international business consultation and services.

The advantages of BITeomics lie in outstanding overseas founder and a large group of professional consultants. With the international advantages, BITeomics has sustainable increasing points for development by integrating all available resources with the lowest cost.

In addition, all the employees of our company hold the degree of bachelor or above. Among them, 10% are doctors and 30% are postgraduates. Meanwhile, we have frontier technologies and finished products. During years ' operation, our company has established broad partnership with universities, research institutions and corporations, such as Clonetech Ltd, Neogeneisis Ltd, Ricam Ltd, Harvard University, Stanford University, NYU Medical School, Tufts University, Colorado University, New England Lab, Altus Ltd, PKC Ltd, TLC Ltd and Kenson Ventures Ltd.

Press Release Source: http://PressExposure.com/PR/BIT.html

Press Release Submitted On: February 01, 2010 at 11:59 pm
This article has been viewed 786 time(s).